LRPPRC缺陷通过磷脂酰肌醇代谢障碍损害滋养细胞功能与复发性流产相关
该研究探讨LRPPRC在复发性流产(RPL)中的作用及机制。通过公共转录组数据再分析、滋养细胞功能实验、11例RPL与11例对照的绒毛脂质组学,以及63例RPL女性孕前血清脂质前瞻队列,发现LRPPRC下调通过破坏磷脂酰肌醇(PI)代谢损害滋养细胞活力并促进凋亡和氧化应激,低孕前血清PI(18:1/18:1)水平与后续流产相关。
要点
- LRPPRC在RPL绒毛组织中下调,敲低后抑制滋养细胞活力并增加凋亡和氧化应激。
- LRPPRC缺陷通过破坏磷脂酰肌醇代谢发挥作用,外源补充PI(18:1/18:1)可逆转细胞缺陷。
- RPL女性孕前血清PI(18:1/18:1)水平低与后续流产相关,或为机制生物标志物。
核心结论
- LRPPRC缺陷通过破坏磷脂酰肌醇代谢损害滋养细胞活力并促进凋亡和氧化应激,低孕前血清PI(18:1/18:1)水平与RPL女性后续流产相关。
研究设计与样本
- 研究包括公共转录组数据集GSE76862再分析、滋养细胞模型功能实验、11例健康孕妇与11例RPL患者早孕期绒毛脂质组学,以及63例有RPL史女性孕前血清脂质前瞻队列(32例正常分娩、31例早期妊娠丢失)。
主要发现
- LRPPRC在RPL绒毛组织中下调,敲低LRPPRC抑制滋养细胞活力并增加凋亡和氧化应激。
- 转录组学和脂质组学共同指向磷脂生物合成通路,RPL绒毛组织中总脂质和特定磷脂降低。
- RPL队列中低孕前血清PI(18:1/18:1)水平预测后续流产。
- 外源补充PI(18:1/18:1)可逆转LRPPRC缺陷所致的细胞缺陷。
临床怎么用
- 孕前血清PI(18:1/18:1)可能作为RPL的机制生物标志物,但需进一步验证。
- 靶向磷脂酰肌醇代谢或为RPL潜在治疗方向,外源PI(18:1/18:1)补充在细胞实验中显示逆转作用。
局限性
- 孕前血清脂质分析仅纳入63例有RPL史女性,样本量相对有限,主要受限于有随访妊娠结局的患者可及性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is leucine-rich pentatricopeptide repeat-containing protein (LRPPRC) involved in the development of recurrent pregnancy loss (RPL) and, if so, what is the potential mechanism? SUMMARY ANSWER: LRPPRC deficiency impairs trophoblast viability and promotes apoptosis and oxidative stress through disruption of phosphatidylinositol (PI) metabolism, and low preconception serum PI (18:1/18:1) levels are associated with subsequent miscarriage in women with RPL. WHAT IS KNOWN ALREADY: RPL is commonly associated with impaired trophoblast function. LRPPRC works as a multifunctional protein that regulates a myriad of biological processes, including energy metabolism. STUDY DESIGN, SIZE, DURATION: The investigation included re-analysis of a public transcriptomic dataset, functional experiments in trophoblast cell models, lipidomic profiling of first-trimester human villous tissues obtained from 11 clinically healthy pregnant women and 11 patients with RPL, and analysis of preconception serum lipids in a cohort of 63 women with a history of RPL, who were prospectively followed for subsequent pregnancy outcomes resulting in 32 normal deliveries and 31 cases of early pregnancy loss. PARTICIPANTS/MATERIALS, SETTING, METHODS: Bioinformatics screening of the public transcriptomic dataset GSE76862 was first conducted to identify candidate genes dysregulated in RPL villous tissues. Following the identification of LRPPRC, its functional role was investigated through siRNA-mediated knockdown in the human trophoblast cells, specifically assessing the resultant effects on cell viability, apoptosis, and oxidative stress levels. To elucidate the downstream molecular pathways, transcriptomic analysis of the LRPPRC-depleted cells was performed. Subsequent Gene Ontology analyses revealed a significant enrichment of candidate differentially expressed genes that are involved in the phospholipid biosynthetic process. In parallel, comprehensive lipidomic profiling of human villous tissue samples from both RPL patients and matched controls was carried out using mass spectrometry to validate bioinformatic predictions at the metabolite level. To explore translational potential, the preconception serum levels of lipids, including PI species, were measured in a cohort of women with a history of RPL and statistically correlated with their subsequent pregnancy outcomes. Finally, direct functional rescue experiments were executed by exogenously supplementing PI (18:1/18:1) to the culture medium of LRPPRC-deficient trophoblast cells to determine if this intervention could reverse the observed phenotypic impairments. MAIN RESULTS AND THE ROLE OF CHANCE: LRPPRC was downregulated in RPL villous tissues. Functional validation in trophoblast cells demonstrated that knockdown of LRPPRC suppressed viability and increased apoptosis/oxidative stress. Transcriptomics and lipidomics converged on the phospholipid biosynthetic pathway as a key downstream process. Total lipids and specific phospholipids were decreased in RPL villous tissues. Low preconception serum PI (18:1/18:1) levels predicted subsequent miscarriage in the RPL cohort. Exogenous PI (18:1/18:1) supplementation reversed the cellular defects caused by LRPPRC deficiency. LARGE SCALE DATA: This study analyzed the publicly available transcriptomic dataset GSE76862 from the Gene Expression Omnibus (GEO) repository. LIMITATIONS AND REASONS FOR CAUTION: The analysis of preconception serum lipids was performed in a cohort of 63 women with a history of RPL. This sample size remains relatively limited, primarily due to the current availability of patients with documented follow-up pregnancy outcomes. WIDER IMPLICATIONS OF THE FINDINGS: Our results reveal a pivotal role for PI in the pathogenesis of RPL and highlight its potential as a mechanistic biomarker and therapeutic target. FUNDING: This study was supported by National Natural Science Foundation of China (82171657 and 81971384) and Shanghai First Maternity and Infant Hospital Basic Research Special Fund (2025A08). DISCLOSURES: The authors have declared no conflict of interest. TRIAL REGISTRATION NUMBER: N/A.
引用
- Wang C, Yang H, Li M, et al. LRPPRC deficiency impairs trophoblast function through disrupted phosphatidylinositol metabolism in recurrent pregnancy loss. Hum Reprod. 2026. PMID: 42515815. doi:10.1093/humrep/deag123
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。